136 related articles for article (PubMed ID: 2488545)
1. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.
Grey AM; Schor AM; Rushton G; Ellis I; Schor SL
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2438-42. PubMed ID: 2488545
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity amongst fibroblasts in the production of migration stimulating factor (MSF): implications for cancer pathogenesis.
Schor SL; Grey AM; Picardo M; Schor AM; Howell A; Ellis I; Rushton G
EXS; 1991; 59():127-46. PubMed ID: 1833226
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: effect on hyaluronic and synthesis.
Schor SL; Schor AM; Grey AM; Chen J; Rushton G; Grant ME; Ellis I
In Vitro Cell Dev Biol; 1989 Aug; 25(8):737-46. PubMed ID: 2768134
[TBL] [Abstract][Full Text] [Related]
4. Detection of migration stimulating activity in wound fluid.
Picardo M; Grey AM; McGurk M; Ellis I; Schor SL
Exp Mol Pathol; 1992 Aug; 57(1):8-21. PubMed ID: 1397194
[TBL] [Abstract][Full Text] [Related]
5. Inter- and intra-site heterogeneity in the expression of fetal-like phenotypic characteristics by gingival fibroblasts: potential significance for wound healing.
Irwin CR; Picardo M; Ellis I; Sloan P; Grey A; McGurk M; Schor SL
J Cell Sci; 1994 May; 107 ( Pt 5)():1333-46. PubMed ID: 7929639
[TBL] [Abstract][Full Text] [Related]
6. Migration stimulating factor (MSF): its structure, mode of action and possible function in health and disease.
Schor SL; Grey AM; Ellis I; Schor AM; Coles B; Murphy R
Symp Soc Exp Biol; 1993; 47():235-51. PubMed ID: 8165568
[TBL] [Abstract][Full Text] [Related]
7. Foetal-to-adult transitions in fibroblast phenotype: their possible relevance to the pathogenesis of cancer.
Schor SL; Schor AM
J Cell Sci Suppl; 1987; 8():165-80. PubMed ID: 3332659
[TBL] [Abstract][Full Text] [Related]
8. Co-expression by keratinocytes of migration stimulating factor (MSF) and a functional inhibitor of its bioactivity (MSFI).
Jones SJ; Florence MM; Ellis IR; Kankova K; Schor SL; Schor AM
Exp Cell Res; 2007 Dec; 313(20):4145-57. PubMed ID: 17949711
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic effects of TGF-beta 1 and MSF on fibroblast migration and hyaluronic acid synthesis. Possible implications for dermal wound healing.
Ellis I; Grey AM; Schor AM; Schor SL
J Cell Sci; 1992 Jul; 102 ( Pt 3)():447-56. PubMed ID: 1506427
[TBL] [Abstract][Full Text] [Related]
10. M(R) 77 KDA factor derived from fibroblasts stimulates the invasion ability of breast-cancer cells.
Ikeda K; Yashiro M; Sawada T; Hato F; Hasuma T; Ishikawa T; Hirakawa-YSChung K
Int J Cancer; 2001 Apr; 92(2):181-6. PubMed ID: 11291043
[TBL] [Abstract][Full Text] [Related]
11. Lubricin is a product of megakaryocyte stimulating factor gene expression by human synovial fibroblasts.
Jay GD; Britt DE; Cha CJ
J Rheumatol; 2000 Mar; 27(3):594-600. PubMed ID: 10743795
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of a fetal fibroblast phenotype in familial breast cancer.
Schor SL; Haggie JA; Durning P; Howell A; Smith L; Sellwood RA; Crowther D
Int J Cancer; 1986 Jun; 37(6):831-6. PubMed ID: 3710614
[TBL] [Abstract][Full Text] [Related]
13. Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells.
Schor SL; Schor AM; Grey AM; Rushton G
J Cell Sci; 1988 Jul; 90 ( Pt 3)():391-9. PubMed ID: 3253289
[TBL] [Abstract][Full Text] [Related]
14. Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics.
Schor SL; Schor AM; Rushton G
J Cell Sci; 1988 Jul; 90 ( Pt 3)():401-7. PubMed ID: 3253290
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of a fetal somatomedin from the sheep: similarity to insulin-like growth factor II.
Hey AW; Browne CA; Thorburn GD
Endocrinology; 1988 Jan; 122(1):12-21. PubMed ID: 3335201
[TBL] [Abstract][Full Text] [Related]
16. Migration stimulating activity in serum of breast cancer patients.
Picardo M; Schor SL; Grey AM; Howell A; Laidlaw I; Redford J; Schor AM
Lancet; 1991 Jan; 337(8734):130-3. PubMed ID: 1670786
[TBL] [Abstract][Full Text] [Related]
17. Purified scatter factor stimulates epithelial and vascular endothelial cell migration.
Rosen EM; Meromsky L; Setter E; Vinter DW; Goldberg ID
Proc Soc Exp Biol Med; 1990 Oct; 195(1):34-43. PubMed ID: 2144630
[TBL] [Abstract][Full Text] [Related]
18. Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells.
Schor SL; Ellis IR; Jones SJ; Baillie R; Seneviratne K; Clausen J; Motegi K; Vojtesek B; Kankova K; Furrie E; Sales MJ; Schor AM; Kay RA
Cancer Res; 2003 Dec; 63(24):8827-36. PubMed ID: 14695199
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast migratory factor derived from mouse colon carcinoma cells: potential roles of fibronectin in tumor stroma formation.
Morimoto M; Irimura T
J Cell Biochem; 2001; 80(4):635-46. PubMed ID: 11169748
[TBL] [Abstract][Full Text] [Related]
20. Migration-stimulating factor displays HEXXH-dependent catalytic activity important for promoting tumor cell migration.
Houard X; Germain S; Gervais M; Michaud A; van den Brûle F; Foidart JM; Noël A; Monnot C; Corvol P
Int J Cancer; 2005 Sep; 116(3):378-84. PubMed ID: 15800942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
